Source:http://linkedlifedata.com/resource/pubmed/id/10476345
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1999-10-7
|
| pubmed:abstractText |
A comparative study of the mitotic index (MI) and karyometric indices in 15 adrenocortical tumors with clinical syndrome of hypercorticism allowed to distinguish between adenomas and carcinomas. Carcinomas with hypercorticoidism symptoms have common features with inactive carcinomas but are different by lower expression of malignancy criteria (polymorphism, atypia, necrotic foci, capsule and vessel invasion), higher MI, increasing deficiency of cell division and larger nuclear size of tumor cells. Such tumors may be included into the prognostic group of risk.
|
| pubmed:language |
rus
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0004-1955
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
61
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
30-4
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:10476345-Adenoma,
pubmed-meshheading:10476345-Adrenal Cortex Neoplasms,
pubmed-meshheading:10476345-Adrenocortical Hyperfunction,
pubmed-meshheading:10476345-Carcinoma,
pubmed-meshheading:10476345-Cell Nucleus,
pubmed-meshheading:10476345-Diagnosis, Differential,
pubmed-meshheading:10476345-Humans,
pubmed-meshheading:10476345-Mitotic Index,
pubmed-meshheading:10476345-Prognosis,
pubmed-meshheading:10476345-Risk Factors
|
| pubmed:articleTitle |
[Adrenocortical tumors: mitotic index and nuclear size as criteria for differential diagnosis and prognosis].
|
| pubmed:affiliation |
M. V. Vladimirsky Moscow Regional Research Clinical Institute, Moscow.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Controlled Clinical Trial
|